Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of NaPi2b-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "B7-H3-Targeted Immunotherapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
-
Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The competitive landscape report...
-
Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Antibody-drug Conjugates (ADCs) in Oncology - Competitive Landscape, 2026" report has been added to ResearchAndMarkets.com's offering.This report...
-
Dublin, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The "Antibody-Drug Conjugate Drug Landscape" report has been added to ResearchAndMarkets.com's offering.This report investigates the impacts and...
-
Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Forecasts (2026-2030) by Cancer, Payload, Target, Product, User and Country/Region with Executive and Consultant...
-
Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Size, Share & Trends Analysis Report by Application (Blood Cancer, Urothelial Carcinoma, Ovarian Cancer, Breast...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "B7-H3-Targeted Immunotherapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of NaPi2b-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The "Rare NRG1 Fusion Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been...